Mrv1718010311712592D 19 19 0 0 0 0 999 V2000 2.0671 -1.8976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2423 -0.2385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7522 0.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9244 1.0099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7090 1.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3219 0.7126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0831 1.8266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8810 2.0717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0323 -0.0519 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.2044 -0.8588 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.4085 -1.4110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2310 -1.6303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1283 -2.0717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9877 -1.1134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2425 -1.8976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.3219 -1.1134 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.6548 -0.6286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.4407 0.3160 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.6128 -0.4909 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 16 2 0 0 0 0 1 15 1 0 0 0 0 3 2 2 0 0 0 0 3 4 1 0 0 0 0 3 9 1 0 0 0 0 5 4 1 0 0 0 0 5 8 1 0 0 0 0 5 7 1 0 0 0 0 5 6 1 0 0 0 0 10 9 1 0 0 0 0 18 9 1 0 0 0 0 14 10 1 0 0 0 0 11 10 1 0 0 0 0 10 19 1 6 0 0 0 11 13 1 0 0 0 0 11 12 1 0 0 0 0 14 17 2 0 0 0 0 14 15 1 0 0 0 0 17 16 1 0 0 0 0 M END > DB08336 > drugbank > [H]N(C(=O)OC(C)(C)C)[C@]([H])(C(C)C)C1=NN=CO1 > InChI=1S/C11H19N3O3/c1-7(2)8(9-14-12-6-16-9)13-10(15)17-11(3,4)5/h6-8H,1-5H3,(H,13,15)/t8-/m1/s1 > PARUDDGQWSBIIO-MRVPVSSYSA-N > C11H19N3O3 > 241.2869 > 241.142641489 > 3 > 36 > 25.253514090286842 > 1 > 1 > 0 > 1 > tert-butyl N-[(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate > 1.20 > 1.1019772786666655 > -2.69 > 0 > 1 > 0 > 12.84773596806209 > -2.385024872340931 > 77.25 > 63.146499999999996 > 5 > 1 > 4.90e-01 g/l > tert-butyl N-[(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate > 0 > DB08336 > experimental > 2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate $$$$